197 related articles for article (PubMed ID: 28574146)
1. Niemann-Pick type C as a cause of progressive intellectual and neurological deterioration in childhood.
Winstone AM; Stellitano LA; Verity CM
Dev Med Child Neurol; 2017 Sep; 59(9):965-972. PubMed ID: 28574146
[TBL] [Abstract][Full Text] [Related]
2. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report.
Degtyareva AV; Mikhailova SV; Zakharova EY; Tumanova EL; Puchkova AA
J Med Case Rep; 2016 Jun; 10(1):143. PubMed ID: 27250337
[TBL] [Abstract][Full Text] [Related]
3. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
Maubert A; Hanon C; Metton JP
Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
[TBL] [Abstract][Full Text] [Related]
4. Niemann-Pick disease type C.
Vanier MT
Orphanet J Rare Dis; 2010 Jun; 5():16. PubMed ID: 20525256
[TBL] [Abstract][Full Text] [Related]
5. Disease and patient characteristics in NP-C patients: findings from an international disease registry.
Patterson MC; Mengel E; Wijburg FA; Muller A; Schwierin B; Drevon H; Vanier MT; Pineda M
Orphanet J Rare Dis; 2013 Jan; 8():12. PubMed ID: 23324478
[TBL] [Abstract][Full Text] [Related]
6. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
[TBL] [Abstract][Full Text] [Related]
7. Early co-occurrence of a neurologic-psychiatric disease pattern in Niemann-Pick type C disease: a retrospective Swiss cohort study.
Abela L; Plecko B; Palla A; Burda P; Nuoffer JM; Ballhausen D; Rohrbach M
Orphanet J Rare Dis; 2014 Nov; 9():176. PubMed ID: 25425405
[TBL] [Abstract][Full Text] [Related]
8. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
[TBL] [Abstract][Full Text] [Related]
9. Niemann-Pick type C: a potentially treatable disorder?
Kheder A; Scott C; Olpin S; Hadjivassiliou M
Pract Neurol; 2013 Dec; 13(6):382-5. PubMed ID: 23906593
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
11. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database.
Imrie J; Heptinstall L; Knight S; Strong K
BMC Neurol; 2015 Dec; 15():257. PubMed ID: 26666848
[TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients.
Hammerschmidt TG; de Oliveira Schmitt Ribas G; Saraiva-Pereira ML; Bonatto MP; Kessler RG; Souza FTS; Trapp F; Michelin-Tirelli K; Burin MG; Giugliani R; Vargas CR
Int J Dev Neurosci; 2018 May; 66():18-23. PubMed ID: 29197565
[TBL] [Abstract][Full Text] [Related]
13. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
Pérez-Poyato MS; Gordo MM; Marfa MP
Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
[TBL] [Abstract][Full Text] [Related]
14. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
[TBL] [Abstract][Full Text] [Related]
15. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C.
Wijburg FA; Sedel F; Pineda M; Hendriksz CJ; Fahey M; Walterfang M; Patterson MC; Wraith JE; Kolb SA
Neurology; 2012 May; 78(20):1560-7. PubMed ID: 22517094
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and gene mutation analysis of patients with Niemann-Pick disease type C].
Ren SC; Tian ZX; Deng YX; Wang YJ; Wu XJ; Zhang YZ; Gao BQ
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(4):284-288. PubMed ID: 29397615
[No Abstract] [Full Text] [Related]
17. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
18. Differences in Niemann-Pick disease Type C symptomatology observed in patients of different ages.
Mengel E; Pineda M; Hendriksz CJ; Walterfang M; Torres JV; Kolb SA
Mol Genet Metab; 2017 Mar; 120(3):180-189. PubMed ID: 27993458
[TBL] [Abstract][Full Text] [Related]
19. Treatable metabolic psychoses that go undetected: what Niemann-Pick type C can teach us.
Klünemann HH; Santosh PJ; Sedel F
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):162-9. PubMed ID: 22746831
[TBL] [Abstract][Full Text] [Related]
20. Niemann-Pick type C: focus on the adolescent/adult onset form.
Di Lazzaro V; Marano M; Florio L; De Santis S
Int J Neurosci; 2016 Nov; 126(11):963-71. PubMed ID: 26998855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
